SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
FDA Calendar Updates: ARDM, BFRM, CRTX, MDT, Zogenix
MDT
|
|
|
+14.25%
in
129 days
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 260 entries as of 7/16/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pendin...
|
ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?
MDT
|
|
|
-9.07%
in
245 days
(closed on 07/16/09)
<> 
<> The accompanying table includes statistics and the top five rated companies in the ETFI Global Health Innovators Index of companies with market caps over $100M which received FDA approval in the trailing 12-month period for either an original new drug or medical device product. The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding reformulations of existing drugs, generic drugs, and label extensions for existing produc...
|
Expanding Defensive Growth Index into Europe
MDT
|
|
|
-4.05%
in
20 days
(closed on 11/12/08)
<> 
<> The accompanying table presents an updated version of the ETFI Highly Defensive PerformIdex, which is expanded to 40 companies with market caps of at least $10B from the industry groups listed below. This defensive growth index is heavily weighted in consumer staples and healthcare and is now structured to include companies based in Europe, in addition to the United States and Canada.
Compared to the previous version, this index has a lower beta and higher average market cap and adds European companie...
|
MDT is a HOLD
MDT
From the Blogosphere
Medtronic Launches New Product – Analyst Blog
|
|
|
Medtronic Inc. (MDT) recently launched a new TSRH 3Dx Spinal System, which is a hook, rod and screw system used in complex spinal procedures. The system offers two screws designed to address multiple pathologies. The Multi Planar Adjusting (MPA) Screw gives surgeons the flexibility of a variable angle posted screw for targeted, controlled correction maneuvers. The OSTEOGRIP Screw enhances bone fixation by incorporating a dual-lead thread pattern that reduces toggle at the bone-screw interface.
<>The new pedicle screw system has a unique technology that addresses multiple spinal pathologies, f...
|
DexCom Loss Narrows – Analyst Blog
|
|
|
DexCom, Inc. (DXCM) reported a net loss of 29 cents per share in the third quarter, 3 cents below the Zacks Consensus Estimate of a net loss of 32 cents and significantly below the year-ago net loss of 53 cents. The significant improvement in financial results was due to higher revenue.
Revenue came in at $7.3 million, up 278% from the $1.9 million reported in the year-ago period. Total revenue consists of product revenue and development grant revenue. Development grant revenue came in at $2.6 million.
Product revenue increased 146% to $4.6 million for the third quarter of 2009. On a sequ...
|
MDT Launches New Bone Grafter – Analyst Blog
|
|
|
<>Medtronic, Inc. (MDT) recently launched MASTERGRAFT Strip - a new, highly flexible ceramic scaffold used in combination with a patient’s own bone for fusing multiple levels of the posterolateral spine, in the U.S. The strip is used by surgeons for a variety of bone grafting procedures.
MASTERGRAFT Strip is primarily used when the spine loses stability or its natural shape. The product offers a continuous latticework for longer grafting procedures at the back of the spine. It also enables maximization of the bony surface area contact and allows for continuous bone growth over large bony g...
|
Medtronic Reports Trial Enrollment – Analyst Blog
|
|
|
Medtronic Inc. (MDT) recently reported the first enrollment for its Attain Success trial. The trial evaluates implant success, complication rates and procedure times for the company’s Attain Family of left-heart leads and delivery systems portfolio which are already available in the market.
The Attain Success trial enrollment will have roughly 2,000 patients at 150 medical centers in 18 countries around the world. The company will analyze data at baseline, implant and three months post-implant. The study will also capture implant success and complication rates (up to three months), proce...
|
Zacks Analyst Blog Highlights: Boston Scientific Corporation, Johnson & Johnson, Medtronic Inc., Abbott Laboratories and St. Jude Medical Inc. – Press Releases
|
|
|
For Immediate Release Chicago, IL – November 11, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Boston Scientific Corporation (BSX), Johnson & Johnson (JNJ), Medtronic Inc. (MDT), Abbott Laboratories (ABT) and St. Jude Medical Inc. (STJ). Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513 <><>Here are highlights from Tu...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
Portfolio results thru 8/8/08
- Portfolio at www.updown.com - started 1/11/08
9.8% return includes dividends and commission.
Started socialpicks on 6/30. some stocks here are not in...
|
Stock update and watch list 7/29/08
- Due to difficulties understanding the socialpicks system regarding changing rating from buy to hold and thus resetting the performance, I wanted to sum...
|
More Resources
|
About Medtronic Inc
- Answers.com
